Hemo Organic share news and announcements

BSE: 524590Commercial Services & SuppliesSmall Cap

₹22.97₹0.00 (0.00%)

Share price at the BSE close on 19 Oct 2026. Previous close ₹22.97.

52-week range of traded prices to 19 Oct 2026

₹8.25Low, 20 Oct 2025₹24.42High, 14 Jul 2026

Under BSE's graded surveillance, stage IV, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹16 Cr4,997th largest listed
P/E: Lossover the last 12 months
P/B: 4.9
Dividend yield: Nonein the last 12 months
ROE: −22.5%
ROCE: −9.1%
Debt to equity: 0.40
Volume, BSE: 5,342

Hemo Organic share news and announcements

522 announcements, routine notices left out, newest first. Page 4 of 11.

Nov 2023
- 2 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve and take on record the unaudited .... (opens in a new tab)
Oct 2023
- 5 Oct · Board meeting
  Meeting on 5 Oct 2023: quarterly results
- 5 Oct · Results
  Board of Directors of the company in their board meeting held on August 15, 2023, have apart from other business considered, approved and taken on record the unaudited standalone financial .... (opens in a new tab)
- 5 Oct · Results
  In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on Tuesday, August 15, 2023, at the registered .... (opens in a new tab)
Sep 2023
May 2023
- 26 May · Non Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  We hereby state that Company is exempt from filing of Related Party Transactions as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 26 May · Results
  Directors of the Company, in their Meeting held on 26/05/2023 , at the Registered Office of the Company which was commenced at 02:30 P.M. and concluded at 03:05 P.M., have, apart from .... (opens in a new tab)
- 23 May · Board meeting
  Meeting on 26 May 2023: audited results
- 20 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 26/05/2023 ,inter alia, to consider and approve and take on record the Audited .... (opens in a new tab)
Apr 2023
- 20 Apr · Submission Of Compliance Certificate In Pursuance Of Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  With reference to captioned subject, please find attached herewith the Compliance Certificate in pursuance of Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, .... (opens in a new tab)
- 15 Apr · Submission Of Certificate Of Practicing Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
  We hereby submit Certificate of practicing Company Secretary under Regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 for the year ended on March 31, 2023. (opens in a new tab)
- 13 Apr · Legal
  We hereby submit reply to BSE for Clarification on Price movement that the movement in Company's share price is purely due to market conditions and apparently market driven on which the .... (opens in a new tab)
- 13 Apr · Legal
  Exchange has sought clarification from Hemo Organic Ltd on April 12, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Feb 2023
- 6 Feb · Results
  Submission of Unaudited Standalone Financial Results of the Company for the quarter ended on December 31, 2022 along with Limited Review Report. (opens in a new tab)
- 6 Feb · Board meeting
  Board of Directors of the Company, in their Board Meeting held on today, i.e. on February 06, 2023, at the Registered Office of the Company which was commenced at 04:00 P.M. and concluded .... (opens in a new tab)
Jan 2023
- 30 Jan · Board meeting
  Meeting on 6 Feb 2023: quarterly results
- 30 Jan · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 06/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 .... (opens in a new tab)
- 9 Jan · Disclosure
  Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhailal Dahyabhai Patel (opens in a new tab)
- 6 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhailal Dahyabhai Patel (opens in a new tab)
- 4 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hetal Yogesh Patel & PACs (opens in a new tab)
Nov 2022
- 28 Nov · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hetal Yogesh Patel & PACs (opens in a new tab)
- 14 Nov · Board meeting
  We hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on November 14, 2022, at the Registered Office of the Company which was commenced .... (opens in a new tab)
- 14 Nov · Results
  In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the followings: .... (opens in a new tab)
- 9 Nov · Board meeting
  Meeting on 14 Nov 2022: quarterly results
- 8 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve and take on record the Un-audited .... (opens in a new tab)
Sep 2022
Aug 2022

Hemo Organic share news and announcements

Nov 2023

Oct 2023

Sep 2023

May 2023

Apr 2023

Feb 2023

Jan 2023

Nov 2022

Sep 2022

Aug 2022